Navigation

Swiss suspend French star cyclist

Richard Virenque has been banned for nine months. Keystone / AP Photo

The Swiss Cycling Federation has suspended for nine months the star French cyclist, Richard Virenque, after he admitted taking performance-enhancing drugs.

This content was published on December 29, 2000 - 12:17

Announcing the decision on Friday, the Federation's director, Walter Leibundgut, said Virenque would have his Swiss cycling licence taken away for nine months, and would be fined SFr4,000 ($2,445).

The ruling follows Virenque's confession last October that he had knowingly taken performance-enhancing drugs before the 1998 Tour de France.

Virenque was acquitted by a court in the French town of Lille last week on charges of supplying banned performance-enhancing drugs to members of his Festina team before the 1998 race.

The International Cycling Union asked the Swiss Cycling Federation in early December to take action against Virenque because he has a home near Geneva and holds a Swiss professional licence.

The ban comes into effect in February - the effective start of the racing season - and means that Virenque will miss all the main races of the season, including the Tour de France.

Virenque said last week that a ban could end his star-studded career. He is currently without a team, having just completed two seasons with Italy's Polti.

The Lille court convicted Festina's former trainer and the former team physiotherapist, as well as six other defendants, for using and administering the banned substances.

swissinfo with agencies

In compliance with the JTI standards

In compliance with the JTI standards

More: SWI swissinfo.ch certified by the Journalism Trust Initiative

You can find an overview of ongoing debates with our journalists here. Please join us!

If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.

Sort by

Change your password

Do you really want to delete your profile?

Your subscription could not be saved. Please try again.
Almost finished... We need to confirm your email address. To complete the subscription process, please click the link in the email we just sent you.

Discover our weekly must-reads for free!

Sign up to get our top stories straight into your mailbox.

The SBC Privacy Policy provides additional information on how your data is processed.